Alkem Lab

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE540L01014
  • NSEID: ALKEM
  • BSEID: 539523
INR
5,262.05
21.1 (0.4%)
BSENSE

Oct 09

BSE+NSE Vol: 1.03 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1000019,
    "name": "Alkem Lab",
    "stock_name": "Alkem Lab",
    "full_name": "Alkem Laboratories Ltd",
    "name_url": "stocks-analysis/alkem-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "5,262.05",
    "chg": 21.1,
    "chgp": "0.4%",
    "dir": 1,
    "prev_price": "5,240.95",
    "mcapval": "62,915.70 Cr",
    "mcap": "Mid Cap",
    "scripcode": 539523,
    "symbol": "ALKEM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE540L01014",
    "curr_date": "Oct 09",
    "curr_time": "",
    "bse_nse_vol": "1.03 lacs",
    "exc_status": "Active",
    "traded_date": "Oct 09, 2026",
    "traded_date_str": "2026 10 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/alkem-lab-1000019-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Alkem Laboratories CFO Nitin Agrawal resigns",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-25 14:27:29",
        "description": "Alkem Laboratories CFO Nitin Agrawal resigns  BusinessLine..."
      },
      {
        "title": "Alkem Laboratories Ltd spurts 2.36%",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-17 13:16:32",
        "description": "Alkem Laboratories Ltd spurts 2.36%  Business Standard..."
      },
      {
        "title": "Alkem Labs launches epilepsy management drug Cenobamate in India",
        "link": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxPUkNwaUxpUXNLamthSW1qb1VSMjhvOHlTZFA3b3VJX3I3U3JZUnRwb0JHNFYyZkdBclRiUGViV2lvbHZxaGVTQW5ja0RTMHhvR2x4dVZFTHViSGhsWmxmd09HTkFQblRUYVZtdzJzdDRZdVNhcVNhMElBdHVqS0w4RFk5dWZWcm9TOFlOUURfa29yTEJHdEtQeUFJc1hoSkJBeUpsNGYwUjlXd0xZMDRUTWdob0FjaFhTN1d3V0xfZ3YwUUtDbVlYb1NpX3J1bFBUcFJvSG4yNnNETUdlME9B0gHkAUFVX3lxTE9IanRsM3Vqb2xnLVMwcEg4T0w1UzI2aGFxbjlWUHBQNEhyOWhJaDVBQnJ2aWQ5ZjdwRHhYTHRIbE1DMlBidVZPZmRxYkRhbGJnQUFPOHNTMkFPdVN0LTRsOXF5cFZVeDNpNUk5a3Bkd21ZVXJMN0ZBS3BnUTh3bjFuZFZ1a3lMYkkza1BaU1p5elVWM29Bb3lndDMxb0wyT3BmNV9RWFFEb0lhLWZNQmMxOTB0OHpOT0p2NmtJX1ZKbjdnaHdQWTZDSkRGTU10clg1a3lVa0ZOTEJka2poS2FOWFN0Rg?oc=5",
        "imagepath": "",
        "date": "2026-09-16 13:04:01",
        "description": "Alkem Labs launches epilepsy management drug Cenobamate in India  Business Standard..."
      },
      {
        "title": "Brokers Call: Alkem Laboratories (Buy)",
        "link": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQaFhEb2ljRXhscGdGMVB2bU1SZDhSZ3NlbkZpa0dXNXBneFpMcmh6Znl0bXNqdlUxS1kzbG5PcXphemYyenA1aERTOEpjeVdHQjE3ZTZ5S2c0UE5sLVFoeTlKR3p4LU1TTEtiTDhOenA0QWIwQnpCNUlMWU9JcENMbXhXaUZ5T2Iyd1I3YWs4bEtYUkdGUS12NW1sYThPMEdsMHfSAagBQVVfeXFMUEFOYkFpOVdsTlZ3UExtNEFJeFR0SFhxNzVxYWg3MmxCWlNUeU9xdGd3Zm1lX2hsUjZJQnBnR3hCdFlyckpqRWlMUlA2cURvTXFQa0lnNGZWdkstbU16WmtCYnVlbUoteXctcmhyN0JmYktsc2I0SWNHZDZhSEh1bjMwWWlpTzhSMUlpN2NUbjBLWkFHUFpVRUxobnVqNHhrY2s0YXhLS3BF?oc=5",
        "imagepath": "",
        "date": "2026-09-01 16:07:04",
        "description": "Brokers Call: Alkem Laboratories (Buy)  BusinessLine..."
      }
    ],
    "total": 4,
    "sid": "1000019",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/alkem-laboratories-1000019"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Cessation",
      "datetime": "24-Sep-2026",
      "details": "Please find attached herewith intimation for change in Key Managerial Personnel - Resignation of Chief Financial Officer",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "23-Sep-2026",
      "details": "Please find attached herewith intimation of Schedule of Analyst / Institutional Investor Meeting.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "22-Sep-2026",
      "details": "Please find attached herewith intimation for closure of trading window.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alkem Laboratories Ltd has declared <strong>500%</strong> dividend, ex-date: 07 Aug 26",
          "dt": "2026-08-07",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Cessation

24-Sep-2026 | Source : BSE

Please find attached herewith intimation for change in Key Managerial Personnel - Resignation of Chief Financial Officer

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

23-Sep-2026 | Source : BSE

Please find attached herewith intimation of Schedule of Analyst / Institutional Investor Meeting.

Closure of Trading Window

22-Sep-2026 | Source : BSE

Please find attached herewith intimation for closure of trading window.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Alkem Laboratories Ltd has declared 500% dividend, ex-date: 07 Aug 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available